PD Dr. Andrea Thoma-Kreß

Medizinische Fakultät Institute of Clinical and Molecular Virology

GRK 2504: Enhancing immunogenicity of Human T-cell leukaemia virus Type 1 (HTLV-1) by interfering with viral transcription (A2) (GRK 2504 A2) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028 HMOs and HTLV-1 (VI-BaCaTec_HMOs and HTLV-1) Jan. 1, 2025 - June 30, 2026 Aufklärung der Virus-Wirt Interaktion zur Inhibition der Transmission des Humanen T-Zell-Leukämievirus Typ 1 (HTLV-1) Nov. 1, 2017 - April 30, 2026 BayFrance FK-24-2024 Jan. 30, 2025 - Jan. 29, 2026 Milk Transmission of Viruses: Prevention of mother to child transmission of Human T-cell leukemia Virus Type 1 (HTLV-1) (Milk-TV) Nov. 1, 2020 - Oct. 31, 2025 Interferenz mit der Spaltung des viralen Proteins p12: Auswirkungen auf Transmission und Persistenz des onkogenen Retrovirus Humanes T-Zell-Leukämie-Virus Typ 1 (VI-Pfleger-Stiftung_virale Protein p12) Aug. 1, 2024 - July 31, 2025 Identification of host restriction factors against Human T-cell leukemia virus (BFHZ_Mobilitätsbeih._ER-Montpellier) Aug. 5, 2014 - Dec. 31, 2023 A091: Interfering with persistence of Human T-cell leukemia virus type 1 by manipulating the accessory protein p8 March 16, 2020 - March 15, 2023 P048: Role of Collagen IV during retrovirus transmission May 16, 2019 - March 15, 2020 Effects of Tax and p8 proteins on cell-to-cell transmission of Human T-cell lymphotropic virus type 1 (HTLV-1) (C06*) (SFB 796) SFB 796: Steuerungsmechanismen mikrobieller Effektoren in Wirtszellen Jan. 1, 2013 - Dec. 31, 2017